Breast Imaging Clinic; University of North Carolina Hospitals
Chapel Hill, North Carolina, 27514, United States
NCT Number: NCT00776126
Mammography remains the current standard in the detection of breast cancer. However, conventional two-view mammography will not detect all cancers. The major limiting factor of conventional mammography is the presence of superimposed breast tissue that can obscure clinically significant lesions. It is this limitation that decreases the sensitivity of mammography and leads to false negative results.
The recent development of digital detectors has allowed imaging technologies such as tomosynthesis to become clinically feasible. The examination, similar to conventional mammography with regard to patient positioning and glandular dose, allows acquisition of a digital data set that can be reconstructed and viewed in multiple sections. The ability of tomosynthesis to unmask overlapping structures has been shown in preliminary studies to increase lesion visibility. Used as either a primary imaging modality, or as an adjunct to screening mammography, tomosynthesis has the potential to provide increased sensitivity and a lower number of false negative examinations.
The purpose of this study is to compare radiologist impression of digital breast tomosynthesis to digital mammography with respect to their ability to see and characterize specific lesion features.
Looking for future studies?
Notify Me18 year and older
Female
Observational
Chapel Hill, North Carolina, 27514, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Digital Breast Tomosynthesis Exam consisting of single view (MLO) of each breast will be performed.
Time frame: upon recruitment/enrollment phase completion
UNC Lineberger Comprehensive Cancer Center
Other
Radiologists' Preference Study - Digital Breast Tomosynthesis
Acronym: NRR
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05181722
Breast Cancer, Breast Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07760714
Breast Cancer, Breast Diseases
East Hanover, New Jersey, United States
View Trial DetailsNCT07764653
Breast Cancer, Breast Diseases
Beijing, Beijing Municipality, China
View Trial DetailsNCT05562518
Breast Cancer, Breast Diseases
Ghent, Belgium
View Trial Details